Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Controlled drug-release system based on pH-sensitive chloride-triggerable liposomes.

Wehunt MP, Winschel CA, Khan AK, Guo TL, Abdrakhmanova GR, Sidorov V.

J Liposome Res. 2013 Mar;23(1):37-46. doi: 10.3109/08982104.2012.727423.

PMID:
23363303
2.

Evaluation of pH-responsive liposomes containing amino acid-based zwitterionic lipids for improving intracellular drug delivery in vitro and in vivo.

Obata Y, Tajima S, Takeoka S.

J Control Release. 2010 Mar 3;142(2):267-76. doi: 10.1016/j.jconrel.2009.10.023. Epub 2009 Oct 25.

PMID:
19861141
3.

pH-sensitive immunoliposomes specific to the CD33 cell surface antigen of leukemic cells.

Simard P, Leroux JC.

Int J Pharm. 2009 Nov 3;381(2):86-96. doi: 10.1016/j.ijpharm.2009.05.013. Epub 2009 May 14.

PMID:
19446624
4.

Intracellular delivery and antitumor effects of pH-sensitive liposomes based on zwitterionic oligopeptide lipids.

Mo R, Sun Q, Li N, Zhang C.

Biomaterials. 2013 Apr;34(11):2773-86. doi: 10.1016/j.biomaterials.2013.01.030. Epub 2013 Jan 23.

PMID:
23352118
5.
6.

Masking and triggered unmasking of targeting ligands on liposomal chemotherapy selectively suppress tumor growth in vivo.

Bandekar A, Zhu C, Gomez A, Menzenski MZ, Sempkowski M, Sofou S.

Mol Pharm. 2013 Jan 7;10(1):152-60. doi: 10.1021/mp3002717. Epub 2012 Dec 18.

PMID:
23134440
7.

Safe and efficient pH sensitive tumor targeting modified liposomes with minimal cytotoxicity.

Wang L, Geng D, Su H.

Colloids Surf B Biointerfaces. 2014 Nov 1;123:395-402. doi: 10.1016/j.colsurfb.2014.09.003. Epub 2014 Sep 15.

PMID:
25438693
8.

Alkylated derivatives of poly(ethylacrylic acid) can be inserted into preformed liposomes and trigger pH-dependent intracellular delivery of liposomal contents.

Chen T, McIntosh D, He Y, Kim J, Tirrell DA, Scherrer P, Fenske DB, Sandhu AP, Cullis PR.

Mol Membr Biol. 2004 Nov-Dec;21(6):385-93.

PMID:
15764368
9.

pH-Cleavable Nucleoside Lipids: A New Paradigm for Controlling the Stability of Lipid-Based Delivery Systems.

Oumzil K, Benizri S, Tonelli G, Staedel C, Appavoo A, Chaffanet M, Navailles L, Barthélémy P.

ChemMedChem. 2015 Nov;10(11):1797-801. doi: 10.1002/cmdc.201500381. Epub 2015 Sep 18.

PMID:
26381578
10.

On the formulation of pH-sensitive liposomes with long circulation times.

Simões S, Moreira JN, Fonseca C, Düzgüneş N, de Lima MC.

Adv Drug Deliv Rev. 2004 Apr 23;56(7):947-65. Review.

PMID:
15066754
11.

Biocompatible magnetic liposomes for temperature triggered drug delivery.

Ding X, Cai K, Luo Z, Li J, Hu Y, Shen X.

Nanoscale. 2012 Oct 21;4(20):6289-92.

PMID:
22976154
12.

Synthesis and characterization of novel zwitterionic lipids with pH-responsive biophysical properties.

Walsh CL, Nguyen J, Szoka FC.

Chem Commun (Camb). 2012 Jun 7;48(45):5575-7. doi: 10.1039/c2cc31710a. Epub 2012 Apr 26.

PMID:
22538384
13.

A review of mechanistic insight and application of pH-sensitive liposomes in drug delivery.

Paliwal SR, Paliwal R, Vyas SP.

Drug Deliv. 2015 May;22(3):231-42. doi: 10.3109/10717544.2014.882469. Epub 2014 Feb 13. Review.

PMID:
24524308
14.
15.

Lipid encapsulation of arsenic trioxide attenuates cytotoxicity and allows for controlled anticancer drug release.

Chen H, MacDonald RC, Li S, Krett NL, Rosen ST, O'Halloran TV.

J Am Chem Soc. 2006 Oct 18;128(41):13348-9.

PMID:
17031934
16.

Design, synthesis and application of vinyl ether compounds for gene and drug delivery.

van den Bossche J, Shin J, Shum P, Thompson DH.

J Control Release. 2006 Nov 28;116(2):e1-3. No abstract available.

PMID:
17718936
17.

Targeting of sterically stabilised pH-sensitive liposomes to human T-leukaemia cells.

Fonseca C, Moreira JN, Ciudad CJ, Pedroso de Lima MC, Simões S.

Eur J Pharm Biopharm. 2005 Feb;59(2):359-66.

PMID:
15661509
18.

Switchable Lipids: Conformational Change for Fast pH-Triggered Cytoplasmic Delivery.

Viricel W, Mbarek A, Leblond J.

Angew Chem Int Ed Engl. 2015 Oct 19;54(43):12743-7. doi: 10.1002/anie.201504661. Epub 2015 Jul 17.

PMID:
26189870
19.

Gel and solid matrix systems for the controlled delivery of drug carrier-associated nucleic acids.

Fattal E, De Rosa G, Bochot A.

Int J Pharm. 2004 Jun 11;277(1-2):25-30.

PMID:
15158966
20.

Reduction-sensitive liposomes from a multifunctional lipid conjugate and natural phospholipids: reduction and release kinetics and cellular uptake.

Goldenbogen B, Brodersen N, Gramatica A, Loew M, Liebscher J, Herrmann A, Egger H, Budde B, Arbuzova A.

Langmuir. 2011 Sep 6;27(17):10820-9. doi: 10.1021/la201160y. Epub 2011 Aug 5.

PMID:
21819046

Supplemental Content

Support Center